Medical & Commercial

Featured

The Fit-for-Purpose Gap: What RWD Still Gets Wrong

In this session, industry experts Dr. Radek Wasiak and Isabella Even-Chen break down the critical "Fit-for-Purpose Gap"—the misstep of assuming a single, generalized dataset can satisfy every study design, regulatory requirement, or health economics endpoint.

Highlight

Medical & Commercial

The Fit-for-Purpose Gap: What RWD Still Gets Wrong

World Orphan Drug Congress Europe: October 26-28 at the RAI Convention Centre in Amsterdam

Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk

How Health Economics and Outcomes Researchers Can Help Defeat COVID-19

Payer Contact in a "Contactless" World: Achieving Early Engagement

A Magnet for the Haystack: Using AI to Find Rare Disease Patients

Building an Enterprise Gateway Marketplace - Kevin Lustig (Scientist.com)

Using AI, NLP and Data Visualization with RWE to Generate Insights into Care Gaps: Retrospective Cohort Analysis of Fracture Risk in Patients with Osteopenia and Osteoporosis

19 Online Marketplaces Facilitating Research in Life Sciences

A Major Milestone for HealthEconomics.Com: A Letter from Dr. Peeples to Our Readers

Addressing a Prominent Health Burden Using Real World Evidence: Management of Heart Failure with Preserved Ejection Fraction

Are you in touch with the latest payer thinking?

Predictive Modeling and Machine Learning: Sharpening the Focus of Real-World Evidence in the Age of Precision Medicine

The things you need to know about the digital transformation of primary research

Payer and HTA submissions: how digital technology is transforming market access processes

The Rise of Altmetrics: Shaping New Ways of Evaluating Research

Horizon Europe: Introducing the EU's New Framework Programme

Tackling Rare Diseases with an Arsenal of Real-World Data

Social Determinants of Health: When Health Care is More Than Just Medicine

US E-Commerce Marketplace for R&D Services Scientist.com Establishes Subsidiary in Tokyo

Optimizing Real-World Evidence in Medical Device Development

Connecting R&D Data: How to Unlock the Potential of Laboratory Resources

Small Pharma Driving Big Pharma Innovation

Best Questions to Ask a CEO (According to the CEOs)

2019 Technology & Telecoms - Highly Commended: Scientist.com

How Artificial Intelligence and Real World Data Can Improve the Management of Type 2 Diabetes: A Case Study

What Do Value Assessments Miss? Rethinking Value Using New Health Economics Evidence.

Using Innovative Data Analytics for Market Access

Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk

The Fit-for-Purpose Gap: What RWD Still Gets Wrong

Filling the Gap: Integrating Patient-Generated Data into Real-World Evidence

Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation

Network meta-analysis and its role in evidence-based decision-making

Sustainable Science: Transforming Pharma-Supplier Partnerships

Addressing Orphan and Rare Diseases - A Cutting Edge Conversation

Joint Clinical Assessment 2025: Pioneering Pathways for Oncology, Advanced Therapies & Rare Diseases

RWE reality check: Routine patient health records and regulatory requirements

"S" Stands for Systematic: Demystifying the Systematic Literature Review

Survival Analysis for Immature Data: A Review of Techniques and Lessons Learned

Market Access - Transforming BioTech Commercial Decisions?

The Scientific and Operational Elegance of Study Replication with Real-World EHR Data: A Vitiligo and Alopecia Example

Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping

Insights from the 2024 Salary Survey Report by HealthEconomics.com

Beyond Accelerated Approvals: External Control Arms

Delphi Panels: What Are They Good For?

Unraveling European Animal Welfare Legislation for Biotech & Pharma

Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches

Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management

Understanding Animal Welfare Best Practices in Asia Pacific for Biotech & Pharma

Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults

Navigating Animal Welfare Legislation in North America: Insights for Biotech & Pharma

Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters

EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025

Cell & Gene Therapies - Beginning with the End in Mind

Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases

Integrating Patient Engagement and Trainee Development in Pre-Clinical Research

Pharma can target ultra-rare conditions ‚Äî the next step is financing them

Transforming Healthcare Using Big Data and Remote Monitoring

Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation

Minimizing the Impact of Cross-Cultural Differences in COA Translations

Synthesise RWE and AI. Transform patient-driven healthcare

Endpoints at #DIA23

Tracking and Measuring Market Access Performance

Certified Corporate Wellness Specialist(CCWS): Is It For Me?

L7|LIVE SF - Tuesday, June 13th, 2023

Transforming clinical research: Scaling real-world data across diseases with expert-led AI

Connected communities: Advancing population health through data and emerging technology

Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials

The reimagined hospital: How health systems are keeping up with new tech

Clinical Trial Innovation: How Healthcare Technology is Evolving

How to assess the quality of AI output when structuring unstructured medical data

Driving value from healthcare data: How integrated cloud-based data is foundational to drive enterprise change

Advancing identity data management for digital engagement: How leading organizations are doing it

How Digital Health Can Empower Cancer Patients

Keeping up with demands for healthcare outside of the hospital: Critical ways tech supports the distributed care model

Closing the gaps of getting data to make decisions

Patient Data: Opportunities for Rare Diseases, Cell and Gene Therapies, and Oncology

Medicare Part D: Price Negotiation Panel Discussion

Notice of Pre-Application Webinar for RFA-AG-24-009, "Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional)"